Episode
The New Era of Patient Empowerment
Summary In this episode, the host discusses the evolving dynamics between patients and physicians in the post-pandemic healthcare landscape. The ...
Physicians: Write thy amicus briefs!
Summary In this episode of the Daily Remedy Podcast, the host discusses the rapidly changing landscape of healthcare laws and ...
Talking physician acquittals with Dr. Rifai
Dr. Muhamad Aly Rifai is a Syrian American internist and psychiatrist and a clinician researcher known for describing the association ...
Talking with Dr. Neil Anand
We speak with physician champion Dr. Neil Anand about his journey to empower physicians disenfranchised by overzealous regulatory agents. #opioids ...
A call to endorse formal complaint against the CDC
We speak with esteemed chronic pain patient advocate, Dr. Richard "Red" Lawhern, to seek endorsements for his formal complaint against ...
Asking for support for IL HB5373
We speak with patient advocate Kat H to garner support for HB5373, a legislative bill that has already passed unanimously ...
Braving through healthcare injustice with Dr. Barbara Marino
We speak with Dr. Barbara Marino, who endured much injustice at the hands of the DEA and DOJ, which remain ...
Daily Remedy health law courses now available
Daily Remedy courses are now available for public consumption. We offer courses on matters of health and law. Please review ...
Exposing DEI in Medicine
Dr. Jeffrey Singer and Professor Erec Smith discuss Diversity, Equity, and Inclusion initiatives in medical schools - and their potential ...
Daily Remedy Courses
Daily Remedy unveiled two courses for physicians and health administrators to participate in. The first course explains how to develop ...
Counterintuitive nature of health policy and healthcare
We discuss the voting power the health issue of abortion carries and how that affects both health policy and healthcare. ...
Reflecting on healthcare trends with Dr. Lynn Webster
Dr. Lynn Webster is a Senior Fellow at the Center for U.S. Policy, specializing in healthcare policy and patient care. He ...
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more